Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(4):537-43
Article Links
Refractory Acquired Amegakaryocytic Thrombocytopenia with Rapid Progression to Aplastic Anaemia in SLE
Bana Hadid1, Arif Kodza1, Sumatha Channapatna Suresh2, Aleksander Feoktistov3
Authors Information

1State University of New York Downstate Health Sciences University, College of Medicine, Brooklyn, NY, USA

2State University of New York Downstate Health Sciences University, Department of Internal Medicine, Brooklyn, NY, USA

3NYC Health and Hospitals/Kings County Hospital Centre, Department of Rheumatology, NY, USA

B Hadid, A Kodza, SC Suresh, A Feoktistov

Keywords: acquired amegakaryocytic thrombocytopenia, AAMT, lupus thrombocytopenia, bone marrow megakaryocyte hypoplasia, refractory thrombocytopenia, early bone marrow transplant
References
  1. Daniel JW. Dubois' lupus erythematosus and related syndromes. 9th edition. Elsevier, 2018.
  2. Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol 2006 Feb;81(2):132-5.
  3. Brown GE, Babiker HM, Cantu CL, Yeager AM, Krishnadasan R. "Almost bleeding to death": the conundrum of acquired amegakaryocytic thrombocytopenia. Case Rep Hematol 2014;2014:806541. doi:10.1155/2014/806541 (2014).
  4. Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006 Jul;45(7):851-4. doi:10.1093/rheumatology/kel010 (2006).
  5. Tirthani E, Said MS, De Jesus O. Amegakaryocytic Thrombocytopenia. 2022 Feb 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–.
  6. Hussain SA, Fatima H, Faisal H, Bansal M. Acquired Amegakaryocytic Thrombocytopenia Progressing to Aplastic Anaemia. Eur J Case Rep Intern Med 2022 Sep 5;9(9):003479. doi:10.12890/2022_003479.
  7. Lu H, Lok AS, Warneke CL, Ahmed S, Torres HA, Martinez F, et al. Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol 2018 Oct;5(10):e474-e478. doi:10.1016/S2352-3026(18)30152-2.
  8. Costa Pires T, Caparrós-Ruiz R, Gaspar P, Isenberg DA. Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis. Clin Exp Rheumatol 2021 May-Jun;39(3):601-5. doi:10.55563/clinexprheumatol/bz64na.
  9. Ahn SM, Choi EJ, Oh JS, Kim YG, Lee CK, Yoo B, et al. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia. Arthritis Res Ther 2022 Sep 6;24(1):213. doi:10.1186/s13075-022-02901-y.
  10. Jiang N, Li M, Zhang M, Xu J, Jiang L, Gong L, et al. Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus. PLoS One 2019 Nov 20;14(11):e0225516. doi:10.1371/journal.pone.0225516.
  11. Lonial S, Bilodeau PA, Langston AA, Lewis C, Mossavi-Sai S, Holden JT, et al. Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature. Bone Marrow Transplant 1999 Dec;24(12):1337-41. doi:10.1038/sj.bmt.1702063.
  12. Nishino S, Kodaka T, Sawada Y, Goka T, Gotoh Y, Tsunemine H, et al. Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia. J Clin Exp Hematop 2018 Dec 13;58(4):166-70. doi:10.3960/jslrt.18016.
  13. Zhao L, Xu D, Qiao L, Zhang X. Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus. J Rheumatol 2016 Jun;43(6):1038-44. doi:10.3899/jrheum.150829.
  14. Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, et al. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus 2008 Mar;17(3):210-4. doi:10.1177/0961203307086032.
  15. Novotný JP, Köhler B, Max R, Egerer G. Acquired Amegakaryocytic Thrombocytopenic Purpura Progressing into Aplastic Anemia. Prague Med Rep 2017;118(4):147-55. doi:10.14712/23362936.2017.16.
  16. King JA, Elkhalifa MY, Latour LF. Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia. South Med J 1997 Jan;90(1):91-4. doi:10.1097/00007611-199701000-00024.
  17. Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, et al. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 2002 Aug;46(8):2148-59. doi:10.1002/art.10420.
  18. Griner PF, Hoyer LW. Amegakaryocytic thrombocytopenia in systemic lupus erythematosus. Arch Intern Med 1970 Feb;125(2):328-32.
  19. Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine. Intern Med 2019 Dec 1;58(23):3473-8. doi:10.2169/internalmedicine.2929-19.
  20. Katsumata Y, Suzuki T, Kuwana M, Hattori Y, Akizuki S, Sugiura H, et al. Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis Rheum 2003 Jun;48(6):1647-51. doi:10.1002/art.10965.
  21. Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, et al. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther 2019 Jun;12(2):115-8. doi: 10.1016/j.hemonc.2017.09.001.
  22. Chaudhary UB, Eberwine SF, Hege KM. Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course. Am J Hematol 2004 Mar;75(3):146-50. doi: 10.1002/ajh.10475.
  23. Cela I, Miller IJ, Katz RS, Rizman A, Shammo JM. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol 2010 Nov;8(11):806-9.
  24. Hill W, Landgraf R. Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine. N Engl J Med 1985 Apr 18;312(16):1060-1.
  25. Trimble MS, Glynn MF, Brain MC. Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin. Am J Hematol 1991 Jun;37(2):126-7. doi: 10.1002/ajh.2830370212.
  26. Manoharan A, Williams NT, Sparrow R. Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature. Q J Med 1989 Mar;70(263):243-52.
  27. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 1991;28:303-12.
  28. Shigekiyo T, Sekimoto E, Shibata H, Ozaki S, Fujinaga H, Hirose T. Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim. Platelets 2015;26(5):504-6. doi: 10.3109/09537104.2014.913128. Epub 2014 May 15.
  29. Wang J, Dai M, Fu Q, Chen S. Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease. Sci Rep 2021 Mar 9;11(1):5459. doi: 10.1038/s41598-021-84493-2.
  30. Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol 2013;98:10-23. doi:10.1007/s12185-013-1382-0.
  31. Cancio M, Hebert K, Kim S, Aljurf M, Olson T, Anderson E, et al. Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia. Transplant Cell Ther 2022 Feb;28(2):101.e1-101.e6. doi: 10.1016/j.jtct.2021.10.009.